All material subject to strictly enforced copyright laws. © 2022 Managing IP is part of the Euromoney Institutional Investor PLC group.

In-house: tough legislation needed to stop fake medicines

Charlotte Kilpatrick
August 20, 2020
Share
medical-counterfeit.jpg

Innovator and generics companies say tougher legislation and more public assistance is needed to help stop a potentially deadly rise in medical counterfeiting

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login

Tags

IP StrategyNewsInternationalPatents
kilpatrick-charlotte-300px.png
Charlotte Kilpatrick
Reporter Managing IP
Contact
Charlotte reports on patent-related issues. She often covers the European market, focusing on developments including FRAND, licensing and trade secrets. She is particularly interested in how new technologies affect IP challenges in the pharmaceutical industry.

More from across our site

GalavaLargeJPEG.jpeg
USPTO cancels first marks under TMA
The USPTO cancelled ‘Galavava’ and 'Surfstar Wake' and partly cancelled ‘Heika’ this month
Rani Mehta, June 30, 2022
Patents
Patent rankings 2022
IP STARS 2022: The full patent rankings
We have published all the 2022 rankings of the leading firms for patent litigation and protection work
Chris Adams, June 30, 2022
Pharmaconcept
UK injunction shift forces pharma to change tack on litigation
In-house and private practice counsel say UK judges have raised the bar for preliminary injunction requests
Rory O’Neill, June 30, 2022
António Campinos wins new EPO term
António Campinos wins new EPO term (but tensions remain)
António Campinos will serve another five years as EPO president – perhaps he’ll calm unrest at the office in that time
Max Walters, June 29, 2022
AdobeStock_277739388.jpg
Firms must go beyond ‘empty’ LGBTQ gestures after pride month
LGBTQ IP lawyers say using rainbow colours and posting solidarity messages on social media must be followed by concrete action
Max Walters, June 29, 2022
Hidden links-comp.jpg
Why brand owners struggle with hidden links
Brand owners bemoan counterfeiters’ latest wheeze and say enforcement authorities should get more involved
Max Walters, June 29, 2022
Covid 19 vaccine
WTO waiver spurs in-house fears of broader deals
Counsel at Bayer, Novartis, a generics company and other firms debate what the WTO’s patent waiver will mean in the short and long term
Rani Mehta, June 29, 2022
Kathi Vidal
Breaking: USPTO releases Section 101 report
The patent office report found that stakeholders were still divided over subject matter eligibility but broadly wanted clarity
Rani Mehta, June 28, 2022
Datamining
UK to expand data mining freedoms for AI
The UKIPO published the results of its consultation on AI and IP today, June 28, and plans to shake up the rules on copyright and data
Rory O’Neill, June 28, 2022
metaverse-comp.jpg
Exclusive: European IP firm to set up metaverse office
IP consultancy Brandit is the first European intellectual property firm to announce plans for an augmented-reality presence
Max Walters, June 28, 2022
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree